They might run some blood tests to tweak your routine based on how youre doing
[3] Cytoreductive therapy [3] [11] [24] [27] Indications [3] [11] [27] High-risk polycythemia vera Low-risk polycythemia vera with any of the following: Polycythemia refractory to phlebotomy Persistent or progressive symptoms despite phlebotomy and aspirin therapy [17] [27] First-line: hydroxyurea [3] [11] Alternatives (e.g., refractory to or unable to tolerate hydroxyurea) [3] [11] JAK2 inhibitor, e.g., ruxolitinib (in patients with symptomatic splenomegaly) Pegylated interferon-alpha Busulfan (in older patients) [11] [15] [27] Further prevention of thromboembolic events [11] [15] [24] All patients: Start antiplatelet drugs (e.g., aspirin ) unless contraindicated
Based on a 2024 review in Antioxidants (Basel) by Tuell et al., "The Role of Glutathione and Its Precursors in Type 2 Diabetes" Spotted in PMC10885928 The Big Question Diabetes is not only about blood sugar
As a result, their patient population, from which they drew their study subjects, may not be representative of the general population
And it didnt find a difference, albeit the study was small, I think it was twenty four patients
Twenty-five patients administered NAC in addition to conventional medical treatments for COPD, did not show improved measure of breathing or earlier hospital release
